Marano Alessandra, Giuffrida Maria Carmela, Giraudo Giorgio, Pellegrino Luca, Borghi Felice
Department of General and Oncologic Surgery , ASO Santa Croce e Carle, Cuneo, Italy .
J Laparoendosc Adv Surg Tech A. 2017 Apr;27(4):342-347. doi: 10.1089/lap.2016.0374. Epub 2016 Oct 28.
Although laparoscopy is becoming the standard of care for the treatment of colorectal disease, its application in case of postoperative peritonitis is still not widespread. The objective of this article is to evaluate the role of laparoscopy in the management of postoperative peritonitis after elective minimally invasive colorectal resection for malignant and benign diseases.
Between April 2010 and May 2016, 536 patients received primary minimally invasive colorectal surgery at our Department. Among this series, we carried out a retrospective study of those patients who, having developed signs of peritonitis, were treated with a laparoscopic reintervention. Patient demographics, type of complication and of the main relaparoscopic treatment, and main outcomes of reoperation were recorded.
A total of 20 patients (3.7%) underwent relaparoscopy for the management of postoperative peritonitis, of which exact causes were detected by laparoscopy in 75% as follows: anastomotic leakage (n = 8, 40%), colonic ischemia (n = 2, 10%), iatrogenic bowel tear (n = 4, 20%), and other (n = 1, 5%). The median time between operations was 3.5 days (range, 2-8). The laparoscopic reintervention was tailored case by case and ranged from lavage and drainage to redo anastomosis with ostomy fashioning. Conversion rate was 10% and overall morbidity was 50%. No cases required additional surgery and 30-day mortality was nil. Three patients (15%) were admitted to intensive care unit for 24-hour surveillance.
Our experience suggests that in experienced hands and in hemodynamically stable patients, a prompt laparoscopic reoperation appears as an accurate diagnostic tool and an effective and safe option for the treatment of postoperative peritonitis after primary colorectal minimally invasive surgery.
尽管腹腔镜检查正成为结直肠疾病治疗的标准方法,但其在术后腹膜炎病例中的应用仍不广泛。本文的目的是评估腹腔镜检查在择期微创结直肠癌切除术后恶性和良性疾病所致术后腹膜炎管理中的作用。
2010年4月至2016年5月期间,536例患者在我科接受了初次微创结直肠手术。在这一系列病例中,我们对那些出现腹膜炎体征并接受腹腔镜再次手术治疗的患者进行了回顾性研究。记录了患者的人口统计学资料、并发症类型、主要腹腔镜再次治疗方式以及再次手术的主要结果。
共有20例患者(3.7%)因术后腹膜炎接受了腹腔镜再次手术,其中75%通过腹腔镜检查明确了确切病因,具体如下:吻合口漏(n = 8,40%)、结肠缺血(n = 2,10%)、医源性肠破裂(n = 4,20%)以及其他(n = 1,5%)。两次手术之间的中位时间为3.5天(范围为2 - 8天)。腹腔镜再次手术根据具体病例进行调整,范围从冲洗引流到带造口重建的再次吻合。中转开腹率为10%,总体发病率为50%。无病例需要额外手术,30天死亡率为零。3例患者(15%)入住重症监护病房进行24小时监测。
我们的经验表明,对于有经验的医生以及血流动力学稳定的患者,及时进行腹腔镜再次手术是一种准确的诊断工具,也是原发性结直肠微创手术后治疗术后腹膜炎的有效且安全的选择。